Robert M. VanHimbergen - 02 Oct 2026 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Reporting relationship: EVP and CFO
Issuer ticker: ELAN
Reported as of: 02 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Oct 2026, 16:35:55 UTC
Prior SEC filing: 22 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen

Key filing fact

Robert M. VanHimbergen filed Form 4 for Elanco Animal Health Inc (ELAN) on 06 Oct 2026.

Key facts

This page summarizes Robert M. VanHimbergen's Form 4 filing for Elanco Animal Health Inc (ELAN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Oct 2026, 16:35.

Change

Previous filing in this sequence was filed on 22 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001724169 Primary reporting owner

VanHimbergen Robert M

Relationship: EVP and CFO
Address: C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen
Signature date: 06 Oct 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELAN transaction Derivative

Deferred Stock Units

Award

Transaction value
Shares: +9
Change %: +5.6%
Price: $22.14^*
Shares after: 168
Date: 02 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

Footnote F2

Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.